宙斯加速器vp-outline

The AIM-HI’s Women’s Venture Competition is a high-profile initiative among women-led oncology start-up companies or venture teams aspiring to soon establish firms. Learn more…

宙斯加速器vp-outline

Most venture capital funds claim to engage in “active management,” while in fact doing little more than assuming passive board roles. AIM-HI is actively involved with each of its portfolio companies. Learn more…

宙斯加速器vp-outline

AIM-HI draws startups from the deep pipeline of National Foundation for Cancer Research (NFCR) funded scientists and the best-in-class global scientist-entrepreneur community. Learn more…

宙斯加速器vp-outline

The AIM-HI Accelerator Fund is an independent 501(C)(3) non-profit organization, established with an initial grant from the National Foundation for Cancer Research with the vision to accelerate the translation of cancer drug discoveries by investing in seed-stage companies. It is a new paradigm through venture philanthropy to fund start-up oncology companies that commercialize innovative laboratory breakthroughs which can potentially save cancer patients’ lives.